We're estimating here that about 20% of the population won't get vaccinated. Some part of that cohort has already had covid (probably at least 25%).They may, but in the U.K. by that time the approval will be virtually irrelevant to use in COVID-19 infections due to vaccination
The odd thing here in terms of cognitive conflict is the same group of folks screaming about variants also talks down things like this prophylactic study in india.
Imagine a variant that wasn't quick to vaccinate against. What's the chance that it would evade this ivermectin prophylactic effect in india? Probably pretty low. If there is efficacy, wouldn't you (talking about everyone) like to be aware that there's an easily produced alternative to bridge to a vaccine update?
Especially given that the drug in this case is proven to have an extremely low side effect profile, and it's persistent in the body, so you don't have to run around and take it every day or multiple times a day. You take it once every several weeks or two times early in a month and then the next month, and the amount taken is small.
To decry this as something dumb to look at or conspiracy theory fodder is dumb. No remdesivir study ever showed efficacy similar to the indian prophylactic study. The only thing we need to wait for is peer review to make sure the study wasn't gamed (but one would hope with the list of doctors involved in the study, that wouldn't be a problem), such as by giving the ivermectin to lower exposure workers in proportion. We can only wait and see. If the study holds up to peer review, it's sheer stupidity not to try to duplicate it in the western world and see if the effect can be observed independently.